CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 273 filers reported holding CONMED CORP in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,118,324 | -26.5% | 80,499 | -0.9% | 0.01% | -27.3% |
| Q2 2023 | $11,043,508 | -16.0% | 81,268 | -35.8% | 0.01% | -15.4% |
| Q1 2023 | $13,153,973 | +19.7% | 126,651 | +2.2% | 0.01% | +8.3% |
| Q4 2022 | $10,988,613 | +4.9% | 123,969 | -5.1% | 0.01% | 0.0% |
| Q3 2022 | $10,471,000 | +1.4% | 130,606 | +21.2% | 0.01% | +9.1% |
| Q2 2022 | $10,323,000 | -42.8% | 107,796 | -11.3% | 0.01% | -26.7% |
| Q1 2022 | $18,046,000 | +7.7% | 121,487 | +2.7% | 0.02% | +66.7% |
| Q4 2021 | $16,762,000 | +19.4% | 118,252 | +10.2% | 0.01% | +12.5% |
| Q3 2021 | $14,042,000 | +4.2% | 107,332 | +9.2% | 0.01% | +14.3% |
| Q2 2021 | $13,474,000 | +51.2% | 98,267 | +44.0% | 0.01% | +40.0% |
| Q1 2021 | $8,913,000 | +145.9% | 68,250 | +110.9% | 0.01% | +150.0% |
| Q4 2020 | $3,625,000 | +117.5% | 32,368 | +52.8% | 0.00% | +100.0% |
| Q3 2020 | $1,667,000 | +1.2% | 21,180 | -7.5% | 0.00% | 0.0% |
| Q2 2020 | $1,648,000 | +43.7% | 22,886 | +14.2% | 0.00% | 0.0% |
| Q1 2020 | $1,147,000 | -70.0% | 20,032 | -41.4% | 0.00% | -66.7% |
| Q4 2019 | $3,825,000 | +44.7% | 34,207 | +24.4% | 0.00% | +50.0% |
| Q3 2019 | $2,644,000 | +26.4% | 27,507 | +12.5% | 0.00% | 0.0% |
| Q2 2019 | $2,091,000 | -5.2% | 24,445 | -7.8% | 0.00% | 0.0% |
| Q1 2019 | $2,205,000 | -45.4% | 26,514 | -57.8% | 0.00% | -50.0% |
| Q4 2018 | $4,036,000 | +123.1% | 62,875 | +175.2% | 0.00% | +100.0% |
| Q3 2018 | $1,809,000 | -13.6% | 22,849 | -20.1% | 0.00% | 0.0% |
| Q2 2018 | $2,093,000 | +1.6% | 28,605 | -12.1% | 0.00% | 0.0% |
| Q1 2018 | $2,060,000 | +25.2% | 32,531 | +0.7% | 0.00% | +100.0% |
| Q4 2017 | $1,646,000 | -13.0% | 32,316 | -10.4% | 0.00% | -50.0% |
| Q3 2017 | $1,892,000 | +86.4% | 36,070 | +81.1% | 0.00% | +100.0% |
| Q2 2017 | $1,015,000 | -14.6% | 19,913 | -25.6% | 0.00% | 0.0% |
| Q1 2017 | $1,189,000 | -12.7% | 26,771 | -13.2% | 0.00% | 0.0% |
| Q4 2016 | $1,362,000 | +29.0% | 30,828 | +16.9% | 0.00% | 0.0% |
| Q3 2016 | $1,056,000 | -4.7% | 26,380 | +13.5% | 0.00% | 0.0% |
| Q2 2016 | $1,108,000 | +35.8% | 23,234 | +19.4% | 0.00% | 0.0% |
| Q1 2016 | $816,000 | +22.5% | 19,466 | +28.9% | 0.00% | 0.0% |
| Q4 2015 | $666,000 | -39.0% | 15,107 | -34.0% | 0.00% | 0.0% |
| Q3 2015 | $1,092,000 | +11.3% | 22,894 | +35.9% | 0.00% | 0.0% |
| Q2 2015 | $981,000 | +49.5% | 16,851 | +29.6% | 0.00% | 0.0% |
| Q1 2015 | $656,000 | -4.0% | 12,998 | -14.3% | 0.00% | 0.0% |
| Q4 2014 | $683,000 | -23.8% | 15,169 | -37.6% | 0.00% | 0.0% |
| Q3 2014 | $896,000 | -77.9% | 24,299 | -73.5% | 0.00% | -66.7% |
| Q2 2014 | $4,049,000 | +95.3% | 91,703 | +92.2% | 0.00% | +50.0% |
| Q1 2014 | $2,073,000 | +147.1% | 47,717 | +141.6% | 0.00% | +100.0% |
| Q4 2013 | $839,000 | -17.0% | 19,748 | -33.7% | 0.00% | 0.0% |
| Q3 2013 | $1,011,000 | +19.4% | 29,794 | +9.8% | 0.00% | 0.0% |
| Q2 2013 | $847,000 | +47.3% | 27,142 | +60.7% | 0.00% | 0.0% |
| Q1 2013 | $575,000 | – | 16,890 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 27,500 | $2,437,600 | 2.23% |
| Ranger Investment Management | 316,318 | $28,038,428 | 2.08% |
| Lighthouse Investment Partners, LLC | 142,100 | $12,595,744 | 1.39% |
| Lighthouse Investment Partners, LLC | 139,200 | $12,338,688 | 1.36% |
| EARNEST PARTNERS LLC | 2,402,352 | $212,944,481 | 1.30% |
| Lighthouse Investment Partners, LLC | 108,200 | $9,590,848 | 1.06% |
| MOODY ALDRICH PARTNERS LLC | 51,885 | $4,599,086 | 0.93% |
| MOUNTAIN PACIFIC INVESTMENT ADVISERS INC/ID | 125,435 | $11,118,558 | 0.81% |
| Champlain Investment Partners, LLC | 1,275,910 | $113,096,662 | 0.72% |
| EPIQ PARTNERS, LLC | 10,463 | $927,440 | 0.62% |